Santa Fe  NM  September 18  2018: Avisa Pharma Inc (“Avisa”) today provided an update on recent progress with its novel rapid  point-of-care breath test – AV BreathTest™ The AV BreathTest is a ten-minute test that can detect and monitor therapy for a wide range of severe respiratory infections with a high degree of sensitivity